Related Experiment Video
Updated: Jan 21, 2026

A Technique to Functionalize and Self-assemble Macroscopic Nanoparticle-ligand Monolayer Films onto Template-free Substrates
Published on: May 9, 2014
Ligand Design for Modulation of RXR Functions
Claudio Martínez1, José A Souto1, Angel R de Lera2
1Departamento de Química Orgánica, Facultade de Química, CINBIO and IBIV, Universidade de Vigo, Vigo, Spain.
Abstract:
Retinoid X receptors (RXRs) are promiscuous partners of heterodimeric associations with other members of the Nuclear Receptor (NR) superfamily. RXR ligands ("rexinoids") either transcriptionally activate the "permissive" subclass of heterodimers or synergize with partner ligands in the "nonpermissive" subclass of heterodimers. The rationale for rexinoid design with a wide structural diversity going from the structures of existing complexes with RXR determined by X-Ray, to natural products and other ligands discovered by high-throughput screening (HTS), mere serendipity, and rationally designed based on Molecular Modeling, will be described. Included is the new generation of ligands that modulate the structure of specific receptor surfaces that serve to communicate with other regulators. The panel of the known RXR agonists, partial (ant)agonists, and/or heterodimer-selective rexinoids require the exploration of their therapeutic potential in order to overcome some of the current limitations of rexinoids in therapy.
Insights
Retinoid X receptors (RXRs) form partnerships with other nuclear receptors. New rexinoids are being designed to target specific receptor surfaces, offering potential therapeutic advancements.
Area of Science:
- Molecular Biology
- Endocrinology
- Drug Discovery
Background:
- Retinoid X receptors (RXRs) are nuclear receptors known for their versatile heterodimerization capabilities.
- RXRs interact with various nuclear receptor (NR) superfamily members, influencing gene transcription.
- RXR ligands, or rexinoids, modulate these interactions, acting as activators or synergists.
Purpose of the Study:
- To describe the rationale behind the structural diversity in rexinoid design.
- To highlight new generations of rexinoids targeting specific receptor surfaces.
- To explore the therapeutic potential of diverse rexinoids, including agonists and selective modulators.
Main Methods:
- X-ray crystallography of RXR-ligand complexes.
- High-throughput screening (HTS) for ligand discovery.
- Molecular modeling and rational drug design.
- Characterization of novel rexinoids and their interactions.
Main Results:
- A wide structural diversity of rexinoids has been explored, derived from various sources.
- New rexinoids are capable of modulating RXR surface structures for targeted regulation.
- The study outlines a panel of RXR agonists, partial agonists, and selective rexinoids.
Conclusions:
- Diverse rexinoid design strategies are crucial for exploring RXR's therapeutic landscape.
- Targeting specific RXR surfaces with novel ligands presents a promising therapeutic avenue.
- Further exploration of rexinoid potential is needed to overcome current therapeutic limitations.
More Related Videos
Related Concept Videos
Ligand Binding and Linkage
Ligand Binding and Linkage
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Group Design

